Subscribe to receive the most important news
The World Health Organization (WHO) said today, Tuesday, that a safety team will review data on the drug hydroxychloroquine by next month, one day after officials rely on safety concerns that led them to stop using malaria treatment in a global experiment on emerging coronavirus patients.
And the organization stopped using the drug in its experiment that includes many countries, after a study published by the British medical journal “The Lancet”, which concluded that the sample of patients who were treated with hydroxychloroquine increased death rates and irregular heartbeat.
US President Donald Trump and others describe hydroxychloroquine as a possible treatment for the disease.
“A final decision regarding the harm, benefit or uselessness of hydroxychloroquine will be taken once the evidence has been reviewed by the Data Safety Supervision Board,” the WHO said. This review will include data from the global experiment (Solidarity) and other ongoing experiments, as well as any published evidence to date. This is expected by mid-June. ”
- The situation in Egypt